Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputationSvea Böhm, Stephan Ehl, Rita Beier et al.|Blood|2023Cited by 41
Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioningKatharina Wustrau, Kai Lehmberg, Johann Greil et al.|Pediatric Blood & Cancer|2020Cited by 19
MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicityKerstin Schütze, Kai Lehmberg, Miriam Groß et al.|Blood Advances|2022Cited by 10